Two Indian drugmakers to end trials of generic Merck pill for moderate COVID-19 | Reuters

Two Indian drugmakers to end trials of generic Merck pill for moderate COVID-19 | Reuters
A source with the Drug Controller General of India said the pill has not shown "significant efficacy" against moderate COVID-19, though it was having success against mild cases.

Comments

Popular posts from this blog

Dams, taps running dry in northern Mexico amid historic water shortages | Nasdaq

The conflict in Gaza: a view from Israel - The Lancet